An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation
- Biomaterials, Available online 10 May 2022 | https://doi.org/10.1016/j.biomaterials.2022.121542